![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia
The interaction between a novel G protein-coupled receptor modulator, N-(2,3-diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) methanamine hydrobromide (SCH-202676), and the M1 muscarinic acetylcholine receptor (mAChR) was investigated. In contrast to the prototypical mAChR allosteric modulator, heptane 1,7-bis-(dimethyl-3'-phthalimidopropyl)-ammonium bromide (C7/3-phth), SCH-202676 had no effect on the dissociation kinetics of [3H]N-methylscopolamine ([3H]NMS) at M1 mAChRs stably expressed in Chinese hamster ovary (CHO) cell membranes. However, SCH-202676 completely inhibited the binding of [3H]NMS in membrane preparations, with a Hill slope significantly greater than unity, indicative of positive cooperativity in the binding of the inhibitor. Moreover, SCH-202676 caused dextral shifts of the [3H]NMS saturation binding curve that were greater than expected for a competitive interaction. The addition of C7/3-phth (100 µM) had no significant effect on the inhibitory potency of SCH-202676. In contrast to the findings in cell membranes, the interaction between SCH-202676 and [3H]NMS in intact M1 CHO cells yielded saturation and inhibition isotherms that were compatible with the predictions for a competitive interaction. Intact cell assays of acetylcholine-mediated phosphoinositide hydrolysis in the absence or presence of SCH-202676 revealed a mixed competitive/noncompetitive mode of interaction that was dependent on the concentration of SCH-202676. These data reveal that the nature of the interaction between SCH-202676 and the M1 mAChR is dependent on whether it is studied using intact versus broken cell preparations. It is proposed that SCH-202676 uses a dual mode of ligand-receptor interaction involving both extra- and intracellular attachment points on the M1 mAChR that are distinct from the allosteric binding site recognized by prototypical mAChR modulators such as C7/3-phth.
Address correspondence to: Dr. Arthur Christopoulos, Department of Pharmacology, University of Melbourne, Grattan St., Parkville, 3010, Victoria, Australia. E-mail: arthurc1{at}unimelb.edu.au
This article has been cited by other articles:
![]() |
A. A. Lanzafame, P. M. Sexton, and A. Christopoulos Interaction Studies of Multiple Binding Sites on M4 Muscarinic Acetylcholine Receptors Mol. Pharmacol., August 1, 2006; 70(2): 736 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Langmead, V. A. H. Fry, I. T. Forbes, C. L. Branch, A. Christopoulos, M. D. Wood, and H. J. Herdon Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist Mol. Pharmacol., January 1, 2006; 69(1): 236 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Veasey, G. Zhan, P. Fenik, and D. Pratico Long-Term Intermittent Hypoxia: Reduced Excitatory Hypoglossal Nerve Output Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 665 - 672. [Abstract] [Full Text] [PDF] |
||||